Showing results (111-120 of 256) with videos related to

Sort By:
Pageof 26
Journal of Medicinal Chemistry|August 11, 2010
Structural and functional basis of resistance to neuraminidase inhibitors of influenza B virusesAaron J Oakley, Susan Barrett, Thomas S Peat, et al.
Vaccine|November 22, 2011
A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in agingHideki Asanuma, Normaiza Binti Zamri, Shinichi Sekine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Comparison of Efficacy of Antimicrobial Agents Among Hospitalized Patients With Mycoplasma pneumoniae Pneumonia in Japan During Large Epidemics of Macrolide-Resistant M. pneumoniae Infections: A Nationwide Observational StudyMasato Tashiro, Kiyohide Fushimi, Kei Kawano, et al.
Antiviral Therapy|January 25, 2006
Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 virusesFrederick Hayden, Alexander Klimov, Masato Tashiro, et al.
Microbiology and Immunology|May 12, 2022
Suitability of NIID-MDCK cells as a substrate for cell-based influenza vaccine development from the perspective of adventitious virus susceptibilityItsuki Hamamoto, Hitoshi Takahashi, Noriko Shimasaki, et al.
Internal Medicine (Tokyo, Japan)|August 2, 2016
Successful Treatment of Aspergillus Empyema Using Open Window Thoracostomy Salvage Treatment and the Local Administration of an Antifungal AgentNobuyuki Ashizawa, Shigeki Nakamura, Shotaro Ide, et al.
BMC Pulmonary Medicine|December 30, 2017
Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumoniaMasato Tashiro, Kiyohide Fushimi, Kei Kawano, et al.
International Journal of Experimental Pathology|November 28, 2007
Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routesNoriyo Nagata, Naoko Iwata, Hideki Hasegawa, et al.
Pageof 26